SCH 42495
Names
[ CAS No. ]:
136511-43-8
[ Name ]:
SCH 42495
[Synonym ]:
N-(2(S)-(ACETYLTHIOMETHYL)-3-(2-METHYLPHENYL)-1-OXOPROPYL)-L-METHIONINE ETHYL ESTER
N-[2(S)-acetylthiomethyl-3-(2-methylphenyl)propionyl]-(S)-methionine ethyl ester
Biological Activity
[Description]:
SCH 42495 is an orally active neutral metalloendopeptidase (NEP) inhibitor with antihypertensive effect. SCH 42495 is the orally active ethylester prodrug of SCH 42354[1].
[Related Catalog]:
[Target]
NEP[1]
[In Vitro]
SCH 42354 selectively inhibits hydrolysis of leu-enkephalin and ANF (IC50 of 8.3 and 10.0 nM, respectively) in vitro[1].
[In Vivo]
SCH 42495 (30 mg/kg; oral gavage; twice daily) causes a significant reduction in the pulmonary vascular remodelling and ventricular hypertrophy in hypoxic rats after 10 days[2]. Treatment with SCH 42495 (30 mg/kg; oral gavage; twice daily) leads to a decrease in cardiovascular remodelling secondary to chronic hypoxia in rats[2]. SCH 42495 (oral doses of 1, 3, or 10 mg/kg) produces significant reductions in blood pressure in DOCA-N a hypertensive rats of 22±6, 43±7, and 62±12 mm Hg, respectively[1]. Animal Model: Hypoxic rats[2] Dosage: 30 mg/kg Administration: Oral gavage; twice daily for 10 days Result: Caused a significant reduction in the pulmonary vascular remodelling and ventricular hypertrophy. Led to a decrease in cardiovascular remodelling secondary to chronic hypoxia.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C20H29NO4S2
[ Molecular Weight ]:
411.57900
[ Exact Mass ]:
411.15400
[ PSA ]:
123.07000
[ LogP ]:
3.62530